Additional information
| Water Retention | Low risk of water retention |
|---|---|
| Hepatotoxicity | Rare hepatotoxic effects |
| Lab Test | Monitoring of serum potassium and renal function recommended |
| Strength | 2.5 MG |
| Also known as | Enalapril maleate |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Trade name | Vasotec, Renitec, Enacard |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (2S)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline, dihydrate |
| Formula | C20H28N2O5В·2H2O |
| Substance class | Angiotensin-converting enzyme (ACE) inhibitor |
| Main action | Lowers blood pressure by inhibiting the conversion of angiotensin I to angiotensin II |
| Half-life | Approximately 11 hours |
| Dosage (medical) | Typically starts at 5 mg once daily, adjusted as needed |
| Dosage (sports) | Not applicable |
| Effects | Reduction in blood pressure, improved heart function |
| Side effects | Cough, hypotension, dizziness, headache, fatigue |
| Use in sports | Not typically used in sports |
| Manufacturer | Intas Pharmaceuticals |
Zoretanin 20 Teva Pharmaceutical
Spiriva HandiHaler 18mg Boehringer Ingelheim
Zyban Glaxosmithkline
Tavanic 500 mg Sanofi
FUCIDIN 500 mg Abdi Ibragim
Prograf 5mg Astellas Pharma
Fostimon (Merional) 75 (HMG) IBSA 

Reviews
There are no reviews yet.